1 / 10

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Baseline characteristics of participants presenting with or without peripheral artery disease (PAD). Heart Protection Study Group J Vasc Surg 2007;45:645-54.

stacy-crane
Télécharger la présentation

Heart Protection Study Group J Vasc Surg 2007;45:645-54

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

  2. Effects of simvastatin allocation on first major coronary event, stroke, or revascularization in participants presenting with or without peripheral artery disease Heart Protection Study Group J Vasc Surg 2007;45:645-54

  3. Absolute effects of simvastatin allocation on 5-year rates of first major vascular events among participants subdivided by prior PAD Heart Protection Study Group J Vasc Surg 2007;45:645-54

  4. Effects of simvastatin allocation on major vascular events in prior disease subgroups Heart Protection Study Group J Vasc Surg 2007;45:645-54

  5. Effects of simvastatin allocation on first major vascular event in participants with or without PAD subdivided by other presenting features Heart Protection Study Group J Vasc Surg 2007;45:645-54

  6. Effects of simvastatin allocation on first and all major vascular events in participants with or without PAD Heart Protection Study Group J Vasc Surg 2007;45:645-54

  7. Effects of simvastatin allocation on first peripheral vascular event subdivided by presenting features Heart Protection Study Group J Vasc Surg 2007;45:645-54

  8. Average use of statin (study or non-study), and average plasma LDL cholesterol concentrations, during follow-up. Table online only Heart Protection Study Group J Vasc Surg 2007;45:645-54

  9. DISCUSSION Heart Protection Study Group J Vasc Surg 2007;45:645-54

  10. INVITED COMMENTARY William R. Hiatt Heart Protection Study Group J Vasc Surg 2007;45:645-54

More Related